MKI67 and diffuse large B-cell lymphoma: In addition, we evaluated the prognosis values of pathological features, such as MYC, BCL-2, BCL-6, Ki-67, coexpression of MYC/BCL-2, and coexpression of MYC/BCL-6 on CD5+ DLBCL.